| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |